Rosacea Features, Historical Subtypes, and Sensitive-Skin Decisions

Clinical Overview of Rosacea

Rosacea is a chronic, relapsing neurovascular and inflammatory dermatosis primarily affecting the convexities of the central face (cheeks, nose, chin, forehead). It is most prevalent in individuals with Fitzpatrick phototypes I and II of Northern European descent, typically emerging between ages 30 and 50. Unlike acne vulgaris, rosacea is fundamentally driven by vascular hyperreactivity, innate immune dysregulation, and barrier compromise rather than follicular hyperkeratinization.

Mechanisms investigated in rosacea

Rosacea is multifactorial. The mechanisms below are research concepts rather than findings that can be confirmed by a cosmetic surface inspection.

Research implicates several interacting pathways, with findings that vary among patients:

1. Neurovascular Hyperreactivity

Facial microcirculation in some rosacea patients displays heightened sensitivity to sensory and thermal stimuli. Investigators have described altered expression or activity of Transient Receptor Potential (TRP) ion channels—specifically TRPV1 (stimulated by heat, capsaicin, and friction) and TRPA1 (stimulated by cold and chemical irritants). Activation prompts the release of vasoactive neuropeptides, including Substance P and Calcitonin Gene-Related Peptide (CGRP). These neuropeptides act on microvascular receptors, producing rapid arteriolar dilation, prolonged flushing, plasma extravasation, and intense burning or stinging sensations.

2. Innate Immune Hyperreactivity (Cathelicidin LL-37 & KLK5)

In healthy epidermis, cathelicidins provide antimicrobial defense. In rosacea, keratinocytes overexpress both the cathelicidin precursor and the epidermal serine protease kallikrein 5 (KLK5). Triggered by Toll-like Receptor 2 (TLR-2), KLK5 cleaves pro-cathelicidin into abnormal, high-concentration fragments of cathelicidin LL-37. Bioactive LL-37 stimulates endothelial proliferation, driving pathological angiogenesis, mast cell degranulation, pro-inflammatory cytokine release (IL-8, TNF-α), and persistent erythema.

3. Microbial Proliferation (Demodex folliculorum)

Higher Demodex densities are reported in some rosacea populations, and inflammatory responses to mites and associated microorganisms have been investigated. These associations do not establish one infectious cause in every patient. An esthetician cannot diagnose mite overgrowth from visible redness or prescribe antimicrobial treatment.

4. Epidermal Barrier Defect & Transepidermal Water Loss (TEWL)

Rosacea skin may exhibit compromised stratum corneum barrier function, marked by elevated TEWL, depleted hydration, and altered ceramide ratios. This defective barrier permits external irritants to penetrate easily, aggravating neurogenic sensitivity.

Historical subtypes and current phenotype approach

Traditional teaching grouped rosacea as erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes. These terms remain useful recognition vocabulary. Modern consensus favors describing the actual phenotype or features rather than forcing every person into one fixed subtype. Persistent facial redness, flushing, papules or pustules, visible vessels, tissue changes, and eye symptoms may coexist.

Medical diagnosis and treatment selection belong to an appropriate clinician. An esthetician records observations and any established diagnosis, identifies triggers reported by the client, and avoids unsuitable irritation or heat. A client's previous rosacea label does not prove that a new painful or changing lesion is part of the same condition.

Distinguish features without ruling out coexistence

Comedones are characteristic of acne and are not a typical rosacea feature. This is a helpful distinction, but acne and rosacea can coexist. The presence of a blackhead does not conclusively exclude rosacea, and redness with pustules does not establish it without medical assessment.

Ask about flushing, sensitivity, triggers, medicines, and eye discomfort. Ocular symptoms warrant appropriate medical evaluation. Do not extract inflammatory lesions or treat the face with strong acids in an attempt to distinguish the conditions.

Cutaneous Vascular Lesions

• Spider Angioma (Nevus Araneus): A central red punctate feeding arteriole with radiating telangiectatic legs. Upon diascopy (pressing with a glass slide), it blanches completely and refills from the center outward.
• Cherry Angioma (Campbell de Morgan Spot): Common, benign, dome-shaped bright red-to-purple papules (1–5 mm) composed of proliferating ectatic capillaries; common on the trunk after age 30.
• Venous Lake (Phlebectasia): A soft, compressible dark blue papule on the sun-exposed lower lip or ear in older adults; empties with firm diascopy.
• Port-Wine Stain (Nevus Flammeus): A congenital vascular malformation of post-capillary venules presenting as a flat pink-to-purple patch that persists throughout life.

Cosmetic support and medical care

Clients may report triggers such as heat, sunlight, particular foods or drinks, or products. Triggers differ. A record of actual individual responses is more useful than instructing every client to avoid every item on a universal list. Gentle compatible cleansing, moisturizing, and sun protection can support comfort within a medical care plan.

Prescription treatments and medical light or laser services require their relevant authority. Do not prescribe azelaic acid at prescription strength, antibiotics, or other medicines as part of an esthetics consultation. A cosmetic preparation's ingredient name does not mean it is equivalent to a medical formulation.

Avoid strong friction, excessive heat, and unsuitable exfoliation on sensitive or inflamed tissue. LED or MLD is not automatically safe or effective for every rosacea presentation; assess the actual device, client, product, and medical instructions. Marketing a lamp as calming does not establish an approved disease treatment.

A client with a medical rosacea diagnosis reports burning after adding a scrub. Record the product and timing, inspect the condition, and avoid another exfoliation. Do not claim that all comedones rule out the diagnosis or that an amber LED will restore lymphatic function. Coordinate significant symptoms with the treating provider.

For exam questions, distinguish historical classification, current observed features, and treatment selection. The first concerns vocabulary, the second concerns assessment, and the third needs client suitability, product/device evidence, and authority. These distinctions prevent a memorized subtype table from becoming an unsafe protocol.

Sources and current rules

Rosacea consensus update; AAD acne/rosacea distinction. Checked October 7, 2026.